Skip to content
CNS Clinical Research

Indiana

CNS clinical trials in Indiana

34 CNS studies are recruiting participants at sites in 13 cities across Indiana as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Indiana city with a recruiting study

By research area: Depression (11), Migraine (7), Parkinson's Disease (7), Multiple Sclerosis (4), Schizophrenia (3), Epilepsy (2).

Indianapolis (20), Fort Wayne (3), Bloomington (2), Carmel (2), Evansville (2), Westfield (2), Avon (1), Goshen (1), Merrillville (1), New Albany (1), Newburgh (1), Richmond (1), West Lafayette (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Indiana

Basic details from each study's public record (the 12 most recently updated of 34). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Goshen · New Albany · Richmond
    Registry record
    NCT06748222 · updated
  2. A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Indianapolis
    Registry record
    NCT07412756 · updated
  3. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Recruiting in
    Bloomington
    Registry record
    NCT07048574 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Indiana on ClinicalTrials.gov.

Parkinson's disease: recently updated in Indiana

  1. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Fort Wayne
    Registry record
    NCT06952504 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Fort Wayne · Indianapolis
    Registry record
    NCT06966700 · updated
  3. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Indianapolis
    Registry record
    NCT06623422 · updated
  4. A Study of Buntanetap in Participants With PD

    • Phase 2/3
    • Ages 40 to 85
    • All sexes
    Sponsor
    Annovis Bio Inc.
    Recruiting in
    Indianapolis
    Registry record
    NCT07284784 · updated
  5. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    • Phase 2
    • Ages 30 to 80
    • All sexes
    Sponsor
    Appello Pharmaceuticals, Inc.
    Recruiting in
    Indianapolis
    Registry record
    NCT07432958 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Indiana on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Indiana

  1. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Indianapolis
    Registry record
    NCT07299019 · updated
  2. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Recruiting in
    Avon
    Registry record
    NCT06433752 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Indiana on ClinicalTrials.gov.

Epilepsy: recently updated in Indiana

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Fort Wayne
    Registry record
    NCT07563881 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Indiana on ClinicalTrials.gov.

Migraine: recently updated in Indiana

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Indianapolis · Merrillville
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Indiana on ClinicalTrials.gov.

Ask about studies in Indiana

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call